Vitamin B12 status in metformin treated patients: systematic review

Qilin Liu, Sheyu Li, Heng Quan, Jianwei Li, Qilin Liu, Sheyu Li, Heng Quan, Jianwei Li

Abstract

Objective: Randomized controlled trials and observational studies have yielded inconsistent results on the effects of metformin on vitamin B12 reduction. We therefore performed a systematic review to analyze the effects of metformin on vitamin B12 concentration.

Methods: PubMed, Medline, Embase, and the Cochrane central registry of controlled trials were searched to identify randomized controlled trials and observational studies exploring the association between metformin and vitamin B12 concentration in patients with type 2 diabetes mellitus or polycystic ovary syndrome. The main outcome measure was changes in serum vitamin B12 concentration after 6-208 weeks of treatment with metformin, as compared with placebo or other anti-hyperglycemic therapy.

Results: Six randomized controlled trials met the inclusion criteria. Serum vitamin B12 concentrations were significantly lower in patients treated with metformin than in those who received placebo or rosiglitazone (mean difference [MD], -53.93 pmol/L; 95% confidence interval [CI], -81.44 to -26.42 pmol/L, P = 0.0001). Subgroup analysis identified four trials in which patients received a lower dose of metformin (<2000 mg/d) and two in which they received a higher dose (≥2000 mg/d), with MDs in vitamin B12 concentration after metformin treatment of -37.99 pmol/L (95% CI, -57.44 to -18.54 pmol/L, P = 0.0001) and -78.62 pmol/L (95% CI, -106.37 to -50.86 pmol/L, P<0.00001), respectively.

Conclusions: The reduction of vitamin B12 may be induced by metformin in a dose dependent manner.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow-chart of the study.
Figure 1. Flow-chart of the study.
Figure 2. Effects of metformin on compared…
Figure 2. Effects of metformin on compared with other interventions vitamin B12 concentration.

References

    1. La Marca A, Artensio AC, Stabile G, Volpe A (2005) Metformin treatment of PCOS during adolescence and the reproductive period. Eur J Obstet Gynecol Reprod Biol 121: 3–7.
    1. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854–865.
    1. Filioussi K, Bonovas S, Katsaros T (2003) Should we screen diabetic patients using biguanides for megaloblastic anaemia? Aust Fam Physician 32: 383–384.
    1. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (2006) Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med 166: 1975–1979.
    1. Wile DJ, Toth C (2010) Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 33: 156–161.
    1. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, et al. (1998) Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus A Population-Based Study. Arterioscler Thromb Vasc Biol 18: 133–138.
    1. Vrbíková J, Bičíková M, Tallová J, Hill M, Stárka L (2002) Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 110: 74–76.
    1. Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available: . Accessed 20 October 2013.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264–269.
    1. Wells GA, Shea B, O'Connell D, Peterson P, Welch V, et al.. (2010) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available: . Accessed 20 October 2013.
    1. Wolever TMS, Assiff L, Basu T, Chiasson JL, Boctor M, et al. (2000) Miglitol, an alpha-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes. Nutrition Research 20: 1447–1456.
    1. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, et al. (2003) Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 54: 455–463.
    1. Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aalan E, et al. (2005) Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study. Hum Reprod 20: 894–899.
    1. Carlsen SM, Kjotrod S, Vanky E, Romundstad P (2007) Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 86: 145–150.
    1. Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND (2007) Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complications 21: 118–123.
    1. de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, et al. (2010) Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. Br Med J 340: c2181.
    1. Kulambil Padinjakara RN, Miriyalaw A, Saravananw P (2009) Association of low vitamin B12 level and ischemic heart disease in diabetes patients. Diabetic Medicine 26: 46.
    1. Toth C (2009) Metformin-associated upregulation in methylmalonic acid levels correlates with clinical deterioration in patients with diabetic peripheral neuropathy. Journal of the Peripheral Nervous System 14: 245–246.
    1. Vischer UM, Ardigo S, Perrenoud L, Genet C, Registe-Rameau Y, et al. (2009) The high prevalence of malnutrition and unnecessary drug therapy in very old diabetic patients. Diabetologia 52: S352–S353.
    1. Calvo C, Michael R, Plodkowski R (2010) The impact of metformin on vitamin B12 levels in subjects with type 2 diabetes. Journal of Investigative Medicine 58: 215.
    1. Plodkowski RA, Chau DL, Michael RL, Calvo CM, Nguyen QT, et al. (2010) The impact of metformin on vitamin B12 levels in older people with type 2 diabetes. J Am Geriatr Soc 58: S185.
    1. Prabhu M, Narmadha MP, Palanisamy A (2010) Assessment of plasma homocysteine, vitamin B12 and folic acid in type II diabetes patients treated with metformin. Indian J Pharm Sci 72: 280.
    1. Gastaldi G, Mura T, Sultan A, Piot C, Cristol J-P, et al. (2011) Metformin, Vit B12 deficiency and silent myocardial ischaemia in type 2 diabetic patients. Diabetologia 54: S500–S501.
    1. Radfar M, Jaberi doost M, Hadjibabaie M, Larijani B (2011) Vitamin B12 levels in type 2 diabetic patients receiving metformin. Int J Clin Pharm 33: 339.
    1. Rajendran R, Brewster S, Partridge H (2011) Metformin, vitamin B12 and diabetes: A retrospective three-year survey of people attending the diabetic neuropathy clinic. Diabetic Medicine 28: 136.
    1. Atwell C, Long A, Yoo W, Solomon S (2012) Metformin and proton pump inhibitors effect on vitamin B12 levels. Journal of Investigative Medicine 60: 435.
    1. Farvid MS, Homayouni F (2012) Factors associated with vitamin B12, folate and homocysteine levels in persons with type 2 diabetes. Clinical Chemistry and Laboratory Medicine 50: A48.
    1. Nag S, Bilous M, Winship S, Bilous R, Jones S (2012) High prevalence of vitamin B12 deficiency in patients on metformin based treatment: Data from the Teesside Anaemia in Diabetes Study. Diabetic Medicine 29: 173.
    1. Narayanan RP, Anderson SG, Onyekwelu E, Heald AH (2012) Vitamin B12 is lower in metformin treated patients but haemoglobin is unaffected. Diabetic Medicine 29: 72.
    1. Nurpeisov V (2012) Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. J Am Geriatr Soc 60: S36.
    1. Morrison CL, Morrison G, Purewal TS, Weston PJ (2013) Anaemia in a primary care population with diabetes. Diabetic Medicine 30: 22.
    1. Tomkin GH, Hadden DR, Weaver JA, Montgomery DA (1971) Vitamin-B12 status of patients on long-term metformin therapy. Br Med J 2: 685–687.
    1. Carpentier JL, Bury J, Luyckx A, Lefebvre P (1976) Vitamin B 12 and folic acid serum levels in diabetics under various therapeutic regimens. Diabete et Metabolisme 2: 187–190.
    1. Adams JF, Clark JS, Ireland JT, Kesson CM, Watson WS (1983) Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 24: 16–18.
    1. Hermann LS, Nilsson B, Wettre S (2004) Vitamin B12 status of patients treated with metformin: A cross-sectional cohort study. British Journal of Diabetes and Vascular Disease 4: 401–406.
    1. Pongchaidecha M, Srikusalanukul V, Chattananon A, Tanjariyaporn S (2004) Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: a cross-sectional study in patients with type 2 diabetes mellitus. Journal of the Medical Association of Thailand 87: 780–787.
    1. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Topolski R (2009) The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: A cross-sectional study. Journal of the American Board of Family Medicine 22: 528–534.
    1. Tal S, Shavit Y, Stern F, Malnick S (2010) Association between vitamin B12 levels and mortality in hospitalized older adults. J Am Geriatr Soc 58: 523–526.
    1. Nervo M, Lubini A, Raimundo FV, Faulhaber GAM, Leite C, et al. (2011) Vitamin B12 in metformin-treated diabetic patients: a cross-sectional study in Brazil. Revista Da Associacao Medica Brasileira 57: 46–49.
    1. Chen S, Lansdown AJ, Moat SJ, Ellis R, Goringe A, et al. (2012) An observational study of the effect of metformin on B12 status and peripheral neuropathy. British Journal of Diabetes and Vascular Disease 12: 189–193.
    1. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley Jr GP (2012) Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: The National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care 35: 327–333.
    1. de Groot-Kamphuis DM, van Dijk PR, Groenier KH, Houweling ST, Bilo HJG, et al. (2013) Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Netherlands Journal of Medicine 71: 386–390.
    1. Obeid R, Jung J, Falk J, Herrmann W, Geisel J, et al. (2013) Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie 95: 1056–1061.
    1. Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T (2013) Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr J 60: 1275–1280.
    1. Tomkin GH (1973) Malabsorption of vitamin B12 in diabetic patients treated with phenformin: a comparison with metformin. Br Med J 3: 673–675.
    1. Greibe E, Trolle B, Bor MV, Lauszus FF, Nexo E (2013) Metformin lowers serum cobalamin without changing other markers of cobalamin status: A study on women with polycystic ovary syndrome. Nutrients 5: 2475–2482.
    1. Kos E, Liszek MJ, Emanuele MA, Durazo-Arvizu R, Camacho P (2012) Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus. Endocrine Practice 18: 179–184.
    1. Caspary W, Creutzfeldt W (1971) Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabtologia 7: 379–385.
    1. Caspary W, Zavada I, Reimold W, Deuticke U, Emrich D, et al. (1977) Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabtologia 13: 187–193.
    1. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V (2000) Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 23: 1227–1231.
    1. Buvat DR (2004) Use of metformin is a cause of vitamin B12 deficiency. Am Fam Physician 69: 264–266.
    1. Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, et al. (2013) Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36: 2981–2987.
    1. Leung S, Mattman A, Snyder F, Kassam R, Meneilly G, et al. (2010) Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients. Clin Biochem 43: 759–760.
    1. Liu KW, Dai LK, Jean W (2006) Metformin-related vitamin B12 deficiency. Age Ageing 35: 200–201.
    1. Callaghan TS, Hadden DR, Tomkin GH (1980) Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment. Br Med J 280: 1214–1215.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する